Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Antitumor agents from Samjin

Sep. 13, 1996

Phase I trial of a new antiangiogenic agent from Daiichi

Sep. 13, 1996

Antiangiogenic eponemycin analogues

Sep. 13, 1996

The Liposome Company prepares and formulates new taxanes

Sep. 13, 1996

Improved camptothecin derivatives

Sep. 13, 1996

New multidrug resistance modulators

Sep. 6, 1996

Otsuka claims agents for cancer metastasis

Sep. 6, 1996

Promising results for lung cancer gene therapy

Sep. 6, 1996

Banyu discloses natural anticancer compounds

Sep. 6, 1996

Anticancer benzodiazepines from Genentech

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...